|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Cytokeratin 8, IHC without Interpretation [19321X]
Test Code19321
CPT Codes
88342
Preferred Specimen
Formalin-fixed, paraffin-embedded block, submitted in IHC Specimen Transport Kit
Other Acceptable Specimens
4-micron unstained glass slides [x5] or fixed tissue or tissue in neutral buffered formalin
Transport Temperature
Room temperature
Specimen Stability
Room temperature: Indefinitely
Refrigerated: Indefinitely
Frozen: Unacceptable
Refrigerated: Indefinitely
Frozen: Unacceptable
Methodology
Immunohistochemistry (IHC)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Mon-Sat; Report available: 2-3 days
Reference Range
See Laboratory Report
Clinical Significance
This marker can be used to aid in the diagnosis and/or prognosis of cancer. The clinical interpretation of any staining or its absence should be complemented by morphological studies using proper controls and should be evaluated within the context of the patient's clinical history and other diagnostic tests by a qualified pathologist.